BREAKTHROUGH DTG PRICE AGREEMENT FOR 90 LMIC COUNTRIES
The first low-price, single-pill antiretroviral treatment is likely to be made available in 90 LMIC (low and middle income) countries thanks to a breakthrough costing agreement for HIV drugs. The regime which contains DTG (dolutegravir) could become extensively available in LMIC countries for about a tenth of the current price – around US $75 per person per year.
The deal came about due to collaborative efforts between.... Read more »
Posted on : Tuesday , 31st October 2017